Previously published studies have reported complement component 3 (C3) in a specific subtype of reactive astrocytes that respond to inflammation and mediate microglia–astrocyte crosstalk in a range of neurodegenerative diseases such as AD, HD, MS, and amyotrophic lateral sclerosis (ALS) [4,26,46]. The gene discussed is C3; the disease is neurodegenerative disease.